[ad_1] The Directorate General of Drugs, Supplies and Medicines (Digemid) of the Ministry of Health (Minsa) ordered the withdrawal of 33 products containing valsartan (active ingredient used for arterial hypertension) in response …
Read More »They order to withdraw from the market drugs with valsatran, in case of possible carcinogenic impurity
